Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
Patient Eligibility for Established and Novel...
Journal article

Patient Eligibility for Established and Novel Guideline-Directed Medical Therapies After Acute Heart Failure Hospitalization

Abstract

BACKGROUND: Acute heart failure (AHF) hospitalization presents an opportunity to optimize pharmacotherapy to improve outcomes. OBJECTIVES: This study's aim was to define eligibility for initiation of guideline-directed medical therapy and newer heart failure (HF) agents from recent clinical trials in the AHF population.

Authors

Moghaddam N; Hawkins NM; McKelvie R; Poon S; Joncas SX; MacFadyen J; Honos G; Wang J; Rojas-Fernandez C; Kok M

Journal

JACC Heart Failure, Vol. 11, No. 5, pp. 596–606

Publisher

Elsevier

Publication Date

May 2023

DOI

10.1016/j.jchf.2022.10.013

ISSN

2213-1779